How to effectively manage the event of bleeding complications when using anticoagulants
Authors:
- Paolo PrandoniPPPaolo Prandoni
- 30 October 2015
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Hematology
- Vol. 9 (1) , 37-50
Abstract
Since affecting hemostasis, all the anticoagulant drugs carry a risk of bleeding. Minor bleeds may be managed without the need to reverse the anticoagulant effect, which is instead a key step to ensure efficacious hemostasis in major and life-threatening bleeding. Drug withdrawal applies to all anticoagulants. Unfractionated heparin can be neutralized by protamine, which may partly neutralize low-molecular-weight heparins. There is no antidote for fondaparinux, and recombinant factor VIIa (rFVIIa) may be considered for critical bleeding. For vitamin K antagonists-induced major bleeding, rapid reversal with prothrombin complex concentrates (PCC) or plasma and intravenous vitamin K to confer lasting correction are recommended. PCC, activated PCC and rFVIIa are suggested for major bleeding related to new direct oral anticoagulants (DOAC), despite proper studies are lacking. Premarketing studies are ongoing on new antidotes (idarucizumab, andexanet, aripazine), which appear to be suitable for the treatment of DOAC-induced life-threatening hemorrhage.Keywords
This publication has 74 references indexed in Scilit:
- Assessment of Anticoagulation Intensity and Management of Bleeding With Old and New Oral AnticoagulantsCanadian Journal of Cardiology, 2013
- Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studiesEP Europace, 2013
- An update of consensus guidelines for warfarin reversalMedical Journal of Australia, 2013
- Antithrombotic Therapy for VTE DiseaseChest, 2012
- Evidence-Based Management of Anticoagulant TherapyChest, 2012
- Early Anticoagulation Is Associated With Reduced Mortality for Acute Pulmonary EmbolismChest, 2010
- Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran EtexilateClinical Pharmacokinetics, 2010
- Toward Rational Fresh Frozen Plasma TransfusionAmerican Journal of Clinical Pathology, 2006
- Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studiesAmerican Heart Journal, 2003
- Utilisation and Safety of Low Molecular Weight HeparinsDrug Safety, 2003